Crispr-Cas9-Mediated Pre-Transcriptional Silencing of Mutant Atxn3 Decreases Motor Impairments of an In Vivo Machado-Joseph Disease Model

AuthID
 P-00Q-G28
7
Author(s)
Matos, C
·
Pena, F
·
Conceicao, A
·
Lopes, S
·
Duarte, S
·
de Almeida, LP
Document Type
Abstract
Year published
2019
Published
in MOLECULAR THERAPY, ISSN: 1525-0016
Volume: 27, Issue: 4, Pages: 120-121 (2)
Conference
22Nd Annual Meeting of the American-Society-Of-Gene-And-Cell-Therapy (Asgct), Date: APR 29-MAY 02, 2019, Location: Washington, DC, Sponsors: Amer Soc Gene & Cell Therapy
Indexing
Wos®
Publication Identifiers
Wos: WOS:000464381001094
Source Identifiers
ISSN: 1525-0016
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service